Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

Too advanced? It's a blood test. The 70 in DR-70 stands for 1970, the year of its creation.

If anything, it is not advanced enough, since it does not tell you where in the body the cancer might be, and fibrinogen is produced for reasons other than cancer.

If this test was valuable, the global medical community would use it.

The streets of biotech are littered with the carcasses of products that received patent approval and FDA clearance but were rejected by the market.